170 related articles for article (PubMed ID: 33381841)
1. DeepCDR: a hybrid graph convolutional network for predicting cancer drug response.
Liu Q; Hu Z; Jiang R; Zhou M
Bioinformatics; 2020 Dec; 36(Suppl_2):i911-i918. PubMed ID: 33381841
[TBL] [Abstract][Full Text] [Related]
2. DeepAEG: a model for predicting cancer drug response based on data enhancement and edge-collaborative update strategies.
Lao C; Zheng P; Chen H; Liu Q; An F; Li Z
BMC Bioinformatics; 2024 Mar; 25(1):105. PubMed ID: 38461284
[TBL] [Abstract][Full Text] [Related]
3. Global proteomics profiling improves drug sensitivity prediction: results from a multi-omics, pan-cancer modeling approach.
Ali M; Khan SA; Wennerberg K; Aittokallio T
Bioinformatics; 2018 Apr; 34(8):1353-1362. PubMed ID: 29186355
[TBL] [Abstract][Full Text] [Related]
4. Predicting cancer drug response using parallel heterogeneous graph convolutional networks with neighborhood interactions.
Peng W; Liu H; Dai W; Yu N; Wang J
Bioinformatics; 2022 Sep; 38(19):4546-4553. PubMed ID: 35997568
[TBL] [Abstract][Full Text] [Related]
5. MMCL-CDR: enhancing cancer drug response prediction with multi-omics and morphology images contrastive representation learning.
Li Y; Guo Z; Gao X; Wang G
Bioinformatics; 2023 Dec; 39(12):. PubMed ID: 38070154
[TBL] [Abstract][Full Text] [Related]
6. GraphCDR: a graph neural network method with contrastive learning for cancer drug response prediction.
Liu X; Song C; Huang F; Fu H; Xiao W; Zhang W
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34727569
[TBL] [Abstract][Full Text] [Related]
7. The prediction of drug sensitivity by multi-omics fusion reveals the heterogeneity of drug response in pan-cancer.
Wang C; Zhang M; Zhao J; Li B; Xiao X; Zhang Y
Comput Biol Med; 2023 Sep; 163():107220. PubMed ID: 37406589
[TBL] [Abstract][Full Text] [Related]
8. DualGCN: a dual graph convolutional network model to predict cancer drug response.
Ma T; Liu Q; Li H; Zhou M; Jiang R; Zhang X
BMC Bioinformatics; 2022 Apr; 23(Suppl 4):129. PubMed ID: 35428192
[TBL] [Abstract][Full Text] [Related]
9. A cross-level information transmission network for hierarchical omics data integration and phenotype prediction from a new genotype.
He D; Xie L
Bioinformatics; 2021 Dec; 38(1):204-210. PubMed ID: 34390577
[TBL] [Abstract][Full Text] [Related]
10. GVDTI: graph convolutional and variational autoencoders with attribute-level attention for drug-protein interaction prediction.
Xuan P; Fan M; Cui H; Zhang T; Nakaguchi T
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34718408
[TBL] [Abstract][Full Text] [Related]
11. Predicting Drug Response Based on Multi-Omics Fusion and Graph Convolution.
Peng W; Chen T; Dai W
IEEE J Biomed Health Inform; 2022 Mar; 26(3):1384-1393. PubMed ID: 34347616
[TBL] [Abstract][Full Text] [Related]
12. Dual-dropout graph convolutional network for predicting synthetic lethality in human cancers.
Cai R; Chen X; Fang Y; Wu M; Hao Y
Bioinformatics; 2020 Aug; 36(16):4458-4465. PubMed ID: 32221609
[TBL] [Abstract][Full Text] [Related]
13. Ensembling graph attention networks for human microbe-drug association prediction.
Long Y; Wu M; Liu Y; Kwoh CK; Luo J; Li X
Bioinformatics; 2020 Dec; 36(Suppl_2):i779-i786. PubMed ID: 33381844
[TBL] [Abstract][Full Text] [Related]
14. KG4SL: knowledge graph neural network for synthetic lethality prediction in human cancers.
Wang S; Xu F; Li Y; Wang J; Zhang K; Liu Y; Wu M; Zheng J
Bioinformatics; 2021 Jul; 37(Suppl_1):i418-i425. PubMed ID: 34252965
[TBL] [Abstract][Full Text] [Related]
15. MOLI: multi-omics late integration with deep neural networks for drug response prediction.
Sharifi-Noghabi H; Zolotareva O; Collins CC; Ester M
Bioinformatics; 2019 Jul; 35(14):i501-i509. PubMed ID: 31510700
[TBL] [Abstract][Full Text] [Related]
16. Hybrid Graph Convolutional Network With Online Masked Autoencoder for Robust Multimodal Cancer Survival Prediction.
Hou W; Lin C; Yu L; Qin J; Yu R; Wang L
IEEE Trans Med Imaging; 2023 Aug; 42(8):2462-2473. PubMed ID: 37028064
[TBL] [Abstract][Full Text] [Related]
17. Chromatin accessibility prediction via a hybrid deep convolutional neural network.
Liu Q; Xia F; Yin Q; Jiang R
Bioinformatics; 2018 Mar; 34(5):732-738. PubMed ID: 29069282
[TBL] [Abstract][Full Text] [Related]
18. Gene-centric multi-omics integration with convolutional encoders for cancer drug response prediction.
Lee M; Kim PJ; Joe H; Kim HG
Comput Biol Med; 2022 Dec; 151(Pt A):106192. PubMed ID: 36327883
[TBL] [Abstract][Full Text] [Related]
19. Neural inductive matrix completion with graph convolutional networks for miRNA-disease association prediction.
Li J; Zhang S; Liu T; Ning C; Zhang Z; Zhou W
Bioinformatics; 2020 Apr; 36(8):2538-2546. PubMed ID: 31904845
[TBL] [Abstract][Full Text] [Related]
20. Modeling gene-wise dependencies improves the identification of drug response biomarkers in cancer studies.
Nikolova O; Moser R; Kemp C; Gönen M; Margolin AA
Bioinformatics; 2017 May; 33(9):1362-1369. PubMed ID: 28082455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
